Statins as potential agents for the prevention and treatment of osteoporosis

Endocrine. 2018 Oct;62(1):269. doi: 10.1007/s12020-018-1650-0. Epub 2018 Jun 17.

Authors

F Kaleağasıoğlu¹, E Olcay², R Onur³

Affiliations

¹ Department of Medical Pharmacology, Faculty of Medicine, Near East University, Near East Boulevard, TRNC Mersin 10, Nicosia, Turkey. ferda.kaleagasioglu@neu.edu.tr.
² Department of Orthopaedic Surgery, Kanuni Sultan Suleyman Educational Hospital, Istanbul, Turkey.
³ Department of Medical Pharmacology, Faculty of Medicine, Near East University, Near East Boulevard, TRNC Mersin 10, Nicosia, Turkey.

PMID: 29911249
DOI: 10.1007/s12020-018-1650-0

No abstract available

Publication types

Letter
Comment

MeSH terms

Animals
Atorvastatin
Bone Density / drug effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Lovastatin
Osteoporosis
Rats
Simvastatin*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lovastatin
Atorvastatin
Simvastatin